[{"Assets_0_Q2_USD":156603000.0,"CommonStockSharesOutstanding_0_Q2_shares":39252294.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14678000.0,"NetIncomeLoss_1_Q2_USD":-7023000.0,"NetIncomeLoss_2_Q2_USD":-16526000.0,"StockholdersEquity_0_Q2_USD":137960000.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]